14.03.2014
Fresenius SE & Co. KGaA DE0005785604
DGAP-Adhoc: Fresenius SE & Co. KGaA: Fresenius proposes three-for-one stock split
Fresenius SE & Co. KGaA / Key word(s): Letter of Intent
14.03.2014 11:46
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Fresenius proposes three-for-one stock split
Fresenius will propose a three-for-one stock split to its Annual General
Shareholder Meeting (AGM) on May 16, 2014. Under this proposal, the
subscribed capital and the number of shares will be tripled. This will be
accomplished by issuing new shares through the conversion of capital
reserves from company funds. Every shareholder will receive two additional
shares for each share held. The share price can be expected to adjust
itself without affecting the overall value for shareholders.
The Fresenius share price has more than tripled in the past 5 years and is
above EUR100. With the stock split, the Company would like to promote
trading activity and increase the stock's attractiveness for a broader
group of investors.
The AGM agenda will be published on April 2, 2014. In accordance with the
proposed stock split, the Company also proposes to adjust the existing
authorized capital and the conditional capitals as well as the
authorization to buy back shares.
The subscribed capital of Fresenius SE & Co. KGaA currently amounts to
EUR179,808,205, divided into 179,808,205 ordinary shares.
Fresenius SE & Co. KGaA,
represented by Fresenius Management SE,
Board of Management
Bad Homburg v.d.H., March 14, 2014
End of note
14.03.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: [email protected]
Internet: www.fresenius.com
ISIN: DE0005785604
WKN: 578560
Indices: DAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard),
München; Freiverkehr in Berlin, Hamburg, Hannover, Stuttgart;
Terminbörse EUREX
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Fresenius SE & Co. KGaA ISIN: DE0005785604 können Sie bei EQS abrufen
Medtech , 578560 , FRE , XETR:FRE